← Evidence map

ReviewPharmacoEconomics1997

Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.

K L Goa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

this paperpooled itcites it

Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis. | OpenQuestion